cement cfo appoint todd young evp cfo effect
nov act cfo luca montarc return cfo
unit follow transit period year-end
remind montarc name act cfo prior ipo process
follow unexpect medic leav previou cfo
encourag montarc ipo process departur
surpris given act cfo statu importantli young
relev experi cfo acadia pharmaceut two year
follow year financ role baxter also involv
spin-off baxalta serv treasur new entiti one year
like help deploy stand-alone compani cost structur initi
relev near term strategi
refin model newli disclos segment fx head
first earn releas disclos new segment speci group
geograph region yesterday adjust model
accordingli consist quarterli disclosur also fine-tun
sale estim reflect updat fx rate base basket
disclos well estim currenc analysi enclos reflect
headwind fx compar rel flat initi
assumpt make chang underli revenu growth
lower top-line assumpt off-set continu aggress cost structur
ep report releas first earn print
public compani nov forecast ep line
consensu constant currenc core revenu growth led
ca diseas prevent benefit easier comparison
due destock trend promot program china
importantli forecast ebitda margin expans bp effici
initi ramp thesi remain highli lever robust industri
fundament ep growth acceler innov effort
dramat improv cost structur nimbl unencumb entiti
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
fourth largest anim health pharmaceut compani
focus develop therapeut supplement
livestock companion anim diversifi portfolio includ
brand market countri
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
grey sky scenario assum draconian
fundament backdrop companion product anim health
fundament greater competit headwind new exist
product line lower expect ramp profit
separ parent specif flat top-line growth
bp ramp profit would translat ep
growth contribut grey sky scenario
blue sky scenario assum greater expect
adopt product launch expedit pipelin success
meaning profit ramp on-going oper effici
initi specif increment million
annual sale product launch increment bp
oper profit margin expans would drive upsid
current ep estim support blue sky scenario
 close
total fx impact million
use previou disclosur vetnosi zoeti estim weight countri previous disclos elanco
